CRH Public vs Eagle Materials
CRH and EXP side by side, both in materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRH and EXP compare
CRH Public is the larger company, worth 11 times as much as Eagle Materials ($60.3B against $5.6B).
On earnings, Eagle Materials is cheaper: it trades at 14.5× trailing earnings, against 17.0× for CRH Public.
CRH Public grew revenue faster over the last twelve months (5.6% versus 1.7% for Eagle Materials).
Eagle Materials keeps more of each dollar of sales as profit, with a net margin of 17.3% compared with 9.2% at CRH Public.
Both pay dividends: CRH Public yields 1.3% and Eagle Materials 0.54%.
CRH Public scores higher on the StockData Score (15 against 12 for Eagle Materials), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRH | EXP |
|---|---|---|
| Size and price | ||
| Market cap | $60.3B | $5.6B |
| Share price | $90.62 | $183.64 |
| Change, 1 year | −24.4% | −21.2% |
| Change, 5 years | 83.1% | 18.0% |
| Beta (5Y) | 1.11 | 1.14 |
| Employees | 83K | 2,800 |
| StockData Score | ||
| Total score | 15 (better) | 12 |
| Valuation score | 4 (better) | 3 |
| Growth score | 2 (better) | 0 |
| Performance score | 4 | 4 |
| Health score | 3 (better) | 2 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 17.0× | 14.5× (better) |
| P/S | 1.5× (better) | 2.4× |
| P/B | 2.4× (better) | 3.8× |
| EV/EBITDA | 10.0× | – |
| P/FCF | 23.7× (better) | 33.0× |
| PEG | 6.70 (better) | 7.90 |
| FCF yield | 4.2% (better) | 3.0% |
| Fair value | $101.39 | $201.06 |
| Margin of safety | 10.6% (better) | 8.7% |
| Growth | ||
| Revenue growth (TTM) | 5.6% (better) | 1.7% |
| Revenue growth, 5Y average | 7.7% (better) | 7.3% |
| Net income growth (TTM) | 4.3% (better) | −11.1% |
| EPS growth (TTM) | 6.0% (better) | −6.8% |
| EPS growth, 5Y average | 31.2% (better) | 10.1% |
| Profitability | ||
| Gross margin | 36.2% (better) | 27.0% |
| Operating margin | 13.7% | – |
| Net margin | 9.2% | 17.3% (better) |
| FCF margin | 6.5% | 7.3% (better) |
| Return on equity | 14.8% | 27.0% (better) |
| Return on invested capital | 10.0% | – |
| Financial health | ||
| Debt / equity | 0.79 (better) | 1.18 |
| Net debt / EBITDA | 1.91 | – |
| Interest coverage | 6.3× | – |
| Current ratio | 1.46 | 3.23 (better) |
| Altman Z-score | 2.68 | 2.72 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% (better) | 0.54% |
| Payout ratio | – | 8.0% |
| Years of dividend growth | 4 (better) | 0 |
| Dividend growth, 5Y average | – | 58.5% |
| Buyback yield | 1.6% | 6.9% (better) |
| Shareholder yield | 2.9% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 84.7% | 108% |
| Held by insiders | 0.15% | 1.2% |
| Insider net buying, 12 months | $445K (better) | −$1.5M |
| Superinvestors holding | 5 (better) | 2 |
| Short interest, % of float | 1.9% | 6.2% |
Go deeper
- CRH stock overview
- CRH income statement
- CRH valuation and score
- EXP stock overview
- EXP income statement
- EXP valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.